Sodium Bicarbonate

CHEMBL1353 Phase 4 Onaylandı Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

84.0 g/mol

LogP

—

Phase

4

Commonly known as baking soda, this medication corrects metabolic acidosis — a build-up of acid in the blood that occurs when the kidneys are failing. It is used in chronic kidney disease to slow disease progression and reduce the bone and muscle breakdown caused by persistently low blood pH.

Moleküler Ağırlık

84,0070 g/mol

TPSA

60,40 Å²

Terapötik Alanlar

Ovarian Cancer Pancreatic Cancer Bladder Cancer Thyroid Cancer Benign Prostatic Hyperplasia Cardiovascular Disease Pain Management Ophthalmology Non-Small Cell Lung Cancer Rheumatoid Arthritis Osteoporosis Asthma Parkinson's Disease Epilepsy Schizophrenia Oncology Nephrology Gastroesophageal Reflux Disease Multiple Sclerosis Chronic Kidney Disease Non-Alcoholic Fatty Liver Disease Stroke Deep Vein Thrombosis / Pulmonary Embolism Obesity Lymphoma Type 2 Diabetes Hypertension Breast Cancer Atopic Dermatitis Gout Chronic Pain Malaria HIV/AIDS Hepatitis C Heart Failure Prostate Cancer Colorectal Cancer Leukemia

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure

Embed this structure

SMILES

O=C([O-])O.[Na+]

InChI

InChI=1S/CH2O3.Na/c2-1(3)4;/h(H2,2,3,4);/q;+1/p-1

Molecular Formula

CHNaO3

HBD / HBA

1 / 3

Döndürülebilir Bağlar

0

Ağır Atomlar

5

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

Commonly known as baking soda, this medication corrects metabolic acidosis — a build-up of acid in the blood that occurs when the kidneys are failing. It is used in chronic kidney disease to slow disease progression and reduce the bone and muscle breakdown caused by persistently low blood pH.

Yes, Sodium Bicarbonate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1353. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 516892. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Hasta dostu bilgi mi arıyorsunuz?

Sodium Bicarbonate PillFYI'da

Yapı

Hızlı Veriler

Formül: CHNaO3
Eş Anlamlılar: 158

Dış Bağlantılar

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.